Broker recommendations for CryoPort
The CryoPort, Inc. stock is rated at 1 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Thursday 20 August, 2020 by a total of 6 brokers. This means that the consensus of the 6 different brokers is leaning toward to .
0 (0%) Underweight
0 (0%) Hold
0 (0%) Overweight
0 (0%) Buy
64 Biggest Movers From Yesterday
Thursday, 27 August 2020, 11:04:18
Gainers BigCommerce Holdings, Inc. (NASDAQ: BIGC ) shares gained 33.5% to close at $139.00 on continued momentum after the company announced a partnership with Facebook. Fluent, Inc. (NASDAQ: FLNT ) gained 31.9% to close at $3.02. Canaccord Genuity initiated coverage on Fluent with a Buy rating and announced a price target of $5. Fluidigm Corporation (NASDAQ: FLDM ) shares jumped 30% to close at $11.43 on Wednesday after the company announced it has received emergency use authorization from the FDA for the Advanta Dx SARS-CoV-2 RT-PCR Assay, an extraction-free saliva-based test to detect nucleic acid from COVID-19. SCWorx Corp. (NASDAQ: WORX ) shares climbed 29.8% to close at $2.1150 on Wednesday after surging over 12% on Tuesday. SCWorx, earlier during the month, appointed Timothy Hannibal as President, COO and Director. Li Auto Inc. (NASDAQ: LI ) shares rose 28.3% to close at $23.38. Li Auto generated $1.1 billion through its IPO last month. Cryoport, Inc. (NASDAQ: CYRX ) shares gained 27.9% to close at $51.51.
Cryoport to Buy Chart’s MVE Biological Unit With Backing From Blackstone | MarketScreener
Tuesday, 25 August 2020, 13:48:02
By Colin Kellaher Cryoport Inc. on Tuesday said it agreed to buy MVE Biological Solutions, the cryobiological products unit of Chart Industries Inc., for $320 million in cash in a deal… | August 25, 2020
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
Tuesday, 25 August 2020, 13:00:00
NASHVILLE, Tenn., Aug. 25, 2020 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced it has signed an agreement to acquire MVE Biological Solutions…
— PR Newswire
60 Biggest Movers From Friday
Monday, 24 August 2020, 11:12:26
Gainers Kymera Therapeutics, Inc. (NASDAQ: KYMR ) shares gained 66.3% to close at $33.26 on Friday after the company priced its 8.684 million share IPO at $20 per share. Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI ) shares jumped 63.9% to close at $0.4602 on Friday after the company announced two additional VenoValve patients from its first-in-man clinical study in Columbia reached the one-year milestone following VenoValve surgery and chronic venous insufficiency significantly improved in both patients. Bio-Path Holdings, Inc. (NASDAQ: BPTH ) shares jumped 31% to close at $5.16. Bio-Path released Q2 results earlier during the month. Harpoon Therapeutics, Inc. (NASDAQ: HARP ) shares rose 30.6% to close at $15.31. Harpoon Therapeutics, earlier during the month, reported a loss for the second quarter. ShiftPixy, Inc (NASDAQ: PIXY ) rose 27% to close at $4.37 after declining 11% in the prior sesion. ShiftPixy announced corporate relocation to Miami, Florida on Thursday. Kelly Services, Inc. (NASDAQ: KELYB ) shares gained 25.8% to close at $31.80.
Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP
Friday, 21 August 2020, 13:30:00
NASHVILLE, Tenn., Aug. 21, 2020 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the expansion of its global supply chain network and services by…
— PR Newswire
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.